CPD and Education library

Study and gain CPD points through OT’s online CPD exams, and access archived CPD and CET articles, Practice team resources and Skills guides in our Education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

In practice

News and in-depth features about business management and career development in optics

Find out more


Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

Steroid implants to treat melanoma associated retinopathy

UK researchers are investigating a new approach to treating a rare auto-immune syndrome in cancer patients

Stethoscope and laptop

Scientists from the University of Surrey and Royal Surrey County Hospital have reported on a new approach to treating melanoma-associated retinopathy (MAR) in JAMA Ophthalmology.
With the support of Moorfields Eye Hospital’s electrophysiology department, the researchers investigated whether long acting steroid implants could improve vision in a 73-year-old patient with MAR.

Improvements in the vision of the patient were observed one week after treatment commenced.

The patient’s vision was monitored over a three-year period, with the patient’s 6/6 vision remaining stable.

Professor of ophthalmology at the University of Surrey, Simon Taylor, said that to his knowledge this is the first time that the vision of a patient with MAR has been treated and significantly improved with long acting steroid implants.

“This offers a possible alternative treatment option to patients whose quality of life is significantly reduced due to the symptoms of this debilitating ailment,” he said.

Image credit: Pexels